Aclarion, Inc.
ACONAclarion is a healthcare technology company that utilizes Magnetic Resonance Spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments for chronic low back and neck pain.
Table of contents
Earnings
Next report
Aug 13, 2026 (in a month)Competitors
By market cap
By revenue growth
Profile
Aclarion is a healthcare technology company that utilizes Magnetic Resonance Spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments for chronic low back and neck pain. The company's platform provides a non-invasive, objective diagnostic tool to identify specific spinal discs as pain generators, assisting surgeons and clinicians in determining optimal treatment paths. By leveraging artificial intelligence and machine learning, Aclarion aims to transform raw spectroscopy data into actionable clinical insights that improve surgical outcomes and reduce healthcare costs.
Aclarion is a pioneer in using MRS-based biomarkers for discogenic pain, offering a non-invasive 'Virtual Discogram' alternative to invasive needle-based provocation tests.
Questions, answered.
- What is Aclarion, Inc.'s market cap?
- Aclarion, Inc. (ACON) has a market capitalization of $7.2M and trades on NASDAQ.
- Who are Aclarion, Inc.'s competitors?
- Aclarion, Inc.'s key competitors include GE HealthCare, Philips Healthcare, Onconetix, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
- Who does Aclarion, Inc. partner with?
- Aclarion, Inc.'s notable partners include Siemens Healthcare GmbH, RadNet, Inc., ATEC Spine, Inc., and others.
- Where is Aclarion, Inc. headquartered?
- Aclarion, Inc. is headquartered in United States of America and employs approximately 6 people. It has been publicly traded since 2022.